Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia.
Journal: Nature cancer
Published: February 19, 2024
Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT.
Journal: Clinical genitourinary cancer
Published: January 11, 2024
When Clot Is Tumor: A Roadmap to Anticoagulation in Renal Cell Carcinoma With Tumor Thrombus.
Journal: JACC. CardioOncology
Published: November 29, 2022
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor-Based Therapy in Patients With Advanced Non-Small-Cell Lung Cancer.
Journal: JAMA oncology
Published: April 15, 2021
Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 31, 2021
Outcomes With First-line PD-1/PD-L1 Inhibition in Advanced Urothelial Cancer: A Single Institution Experience.
Journal: Clinical genitourinary cancer
Published: April 12, 2019
The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients.
Journal: Journal for immunotherapy of cancer
Published: March 07, 2019
Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience.
Journal: Therapeutic advances in urology
Published: November 01, 2018
PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials.
Journal: Clinical genitourinary cancer
Published: September 20, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026